Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Suffers First Hep C Drug Setback
TheStreet.com
Friday, February 17, 2012 - 9:05am
tags:
Gilead, hepatitis C, GS-7977
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
TheStreet.com
Friday, February 17, 2012 - 9:05am
tags:
Vivus, Chelsea Therapeutics, Keryx, Biocryst, Exelixis, BioSante
Alexza Prices $22 Million Public Offering
Yahoo
Friday, February 17, 2012 - 9:03am
tags:
Alexza, stock offering
Avanir Pharmaceuticals: Limelight On The Horizon
Seeking Alpha
Friday, February 17, 2012 - 9:02am
tags:
Avanir, Nuedexta
J&J recalls infant Tylenol over dosing system flaw
Reuters
Friday, February 17, 2012 - 9:01am
tags:
Tylenol, recalls, JNJ
Abbott Laboratories: An Attractively Valued Dividend Aristocrat
Seeking Alpha
Friday, February 17, 2012 - 9:01am
tags:
Abbott Laboratories
5 Innovative Healthcare Companies With Histories Of Strong Growth
Seeking Alpha
Friday, February 17, 2012 - 9:00am
tags:
Abbott Laboratories, Novartis, JNJ, Allergan, Amgen
J&J’s Risperdal Wasn’t Factor in Man’s Diabetes, Jury Rules
Bloomberg
Thursday, February 16, 2012 - 5:24pm
tags:
diabetes, JNJ, Risperdal
[video] Idenix Pharmaceuticals Is Looking For Partners
TheStreet.com
Thursday, February 16, 2012 - 5:23pm
tags:
Indenix, M&A
Acorda 4Q profit climbs; company buying Neuronex
Yahoo/AP
Thursday, February 16, 2012 - 5:23pm
tags:
Neuronex, M&A, earnings, Acorda
The Big Bet on Corcept
Motley Fool
Thursday, February 16, 2012 - 5:21pm
tags:
Corcept, Korlym, Cushing's syndrome
10 Biotech Stocks With Big Potential Upside In 2012: Part III
Seeking Alpha
Thursday, February 16, 2012 - 5:21pm
tags:
Spectrum Pharmaceuticals, Questcor, ImmunoCellular
Fake Avastin may not be the only counterfeit on doctors' shelves
Fierce Pharma
Thursday, February 16, 2012 - 11:44am
tags:
Avastin, Roche, drug counterfeiting, Herceptin, Rituxan
Novartis Steps Up Investments in Taiwan
Taiwan Economic News
Thursday, February 16, 2012 - 11:43am
tags:
Novartis, Taiwan
Sandoz buys German rights to Apricus' sex drug
Reuters
Thursday, February 16, 2012 - 11:25am
tags:
Germany, Apricus Biosciences, Vitaros, Sandoz, Novartis
3 Highly Shorted Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Thursday, February 16, 2012 - 11:22am
tags:
Vivus, Seattle Genetics, Amyris
1-Star Stocks Poised to Plunge: Regeneron?
Motley Fool
Thursday, February 16, 2012 - 11:21am
tags:
Regeneron
2-Star Stocks Poised to Plunge: ISTA Pharmaceuticals?
Motley Fool
Thursday, February 16, 2012 - 11:21am
tags:
ISTA Pharmaceuticals
Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
Yahoo
Thursday, February 16, 2012 - 11:20am
tags:
Pfizer, Mylan, auto-injectors, settlements, Meridian Medical Technologies, e-cue
Why I'm A Near-Term Bear On These 4 Healthcare Stocks
Seeking Alpha
Thursday, February 16, 2012 - 11:19am
tags:
Abbott Laboratories, Merck, Pfizer, Boston Scientific

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.